BTG Blend (BPC-157, TB-500, GHK-Cu)Also known as: Body Protection Compound-157, Thymosin Beta-4, GHK-Cu peptide, GLOW Blend

Mechanism of Action

The BTG Blend synergistically combines BPC-157, TB-500, and GHK-Cu peptides. BPC-157 promotes tissue repair primarily via upregulation of vascular endothelial growth factor (VEGF), enhancing angiogenesis and accelerating wound healing. TB-500 acts by promoting cell migration, modulating actin dynamics, and stimulating angiogenesis, facilitating broader cellular regeneration. GHK-Cu stimulates collagen synthesis, exhibits antioxidant activity, and modulates gene expression to improve skin regeneration and reduce inflammation. Together, these peptides enhance tissue repair, reduce inflammation, support neuroprotection, and promote skin rejuvenation through complementary molecular pathways.

Reported Research Benefits

Preclinical research examining effects on muscle recovery, tendon and ligament healing, wound healing, angiogenesis enhancement, collagen synthesis for skin repair, anti-inflammatory effects, neuroprotection and nerve regeneration, and potential applications in anti-aging treatments.

Dosing Protocol & Reconstitution

Typically supplied as lyophilized powder to be reconstituted with bacteriostatic water. Common experimental administration involves subcutaneous injection using insulin syringes. Doses in research commonly range around 10 mg each for BPC-157 and TB-500, and 50 mg for GHK-Cu per vial. Refrigerated storage (2–8°C) after mixing, with stability up to 60 days.

Research Notes

Extensively studied in animal models for enhanced tissue repair and regeneration, including muscle, skin, nerve, and connective tissue. The blend shows synergistic efficacy in accelerating healing processes, reducing inflammatory markers, and promoting angiogenesis. Clinical data in humans are lacking; all studies remain preclinical. Half-lives of individual peptides vary; BPC-157 shows rapid clearance yet prolonged biological effects, TB-500 has moderate systemic persistence, and GHK-Cu is stable with notable gene regulatory functions.

Research Summary

BTG Blend combines BPC-157 (tissue healing and gastroprotection), TB-500 (systemic anti-inflammation and cell migration), and GHK-Cu (collagen production and gene expression modulation). This combination is used in protocols targeting musculoskeletal recovery, skin health, and systemic anti-aging.

Side Effects & Safety

Cumulative side effect profile of all three components. No human trial data for this specific combination. Injection site reactions possible. Copper accumulation is unlikely at standard research doses.

Stability & Storage

Refer to research notes

Molecular Data

Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Val-Val-Thr-Gly-Glu-Leu

Primary literature: https://pubmed.ncbi.nlm.nih.gov/?term=BPC-157+GHK-Cu+TB-500+regeneration